摘要
目的运用基因工程方法获得重组小鼠β-防御素3(MBD3),优化表达条件,并研究其抗菌活性。方法通过反转录PCR方法从小鼠肺组织中扩增Mbd3基因,构建其原核表达质粒,将该质粒转入大肠埃希菌表达菌株Rosetta-gami(2)。优化融合蛋白的表达条件。通过亲和层析、凝血酶酶切、超滤浓缩得到MBD3的重组成熟肽(rMBD3),并采用十二烷基硫酸钠-聚丙烯酰胺凝胶(SDS-PAGE)电泳和Western blot鉴定其正确性。采用微量液体抗菌实验检测rMBD3对多种常见病原性细菌和真菌的抗菌活性。结果获得表达MBD3融合蛋白(fMBD3)的工程菌,fMBD3的表达量可达菌体总蛋白的62.9%,可溶性fMBD3约为1.15g/L。纯化的rMBD3对单细胞真菌和革兰阳性菌显示出较好的抑菌活性。结论 rMBD3具有一定的抗菌活性,为进一步研究该多肽的其他生物学活性及其应用提供参考依据。
Objective To obtain the recombinant mouse β-defensin-3(MBD3) peptide by genetic engineering,optimize the expression condition and detect the antifungal activity of MBD3. MethodsThe full-length of Mbd3 gene was amplified from the lung tissues of BALB/c mouse after injection of lipopolysaccharide by reverse transcription-PCR to construct the prokaryotic expression plasmid,which was cloned into the pET-32a(+) expression vector and then transferred into Escherichia coli expression strain Rosetta-gami(2).The expression conditions of fusion protein were optimized.The recombinant mature peptide of MBD3(rMBD3) was obtained by affinity chromatography,thrombin digestion and ultrafiltration,and identified by SDS-PAGE electrophoresis and Western blot.The antimicrobial and antifungal activities of rMBD3 were detected by micro-fluid test. Results The Rosetta-gami(2)-pET32a(+)/MBD3 was successfully constructed.Under the optimal conditions,the fMBD3 expression occupied 62.9% of the total bacterial protein,and soluble fMBD3 was about 1.15g/L.The rMBD3 was correctly expressed by SDS-PAGE and Western blot.The inhibitory activity of purified rMBD3 against monoplast eumycete and Gram-positive bacteria was confirmed. Conclusion The rMBD3 has inhibitory activity against some pathogens,which may provide an useful foundation for further study of its other biological activity.
出处
《江苏医药》
CAS
北大核心
2013年第2期128-131,共4页
Jiangsu Medical Journal
基金
贵州省科技厅联合基金项目[黔科合(2010)3143]